Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab
-
Brunner, Patrik M. (Medical University of Vienna)
;
Conrad, Curdin (Lausanne University Hospital) ;
Vender, Ronald (Dermatrials Research Inc) ;
Grond, Susanne (Eli Lilly and Company, Indianapolis) ;
Schuster, Christopher F. (Eli Lilly and Company, Indianapolis) ;
Patel, Hanna (Eli Lilly and Company, Indianapolis) ;
Xu, Wen (Eli Lilly and Company, Indianapolis) ;
Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
visitant ::
identificació
Subscriure's to this discussion. You will then receive all new comments by email.
